Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/1997
05/27/1997US5633247 Nitrogen-containing spirocycles
05/27/1997US5633237 Imidazo[1,2-a]pyridinylalkyl phosphonic acid compounds for treatment of neurotoxic injury
05/22/1997WO1997018212A1 Aryl and heteroaryl purine compounds
05/22/1997WO1997018194A1 CYCLIC AND HETEROCYCLIC N-SUBSTITUTED α-IMINOHYDROXAMIC AND CARBOXYLIC ACIDS
05/22/1997WO1997017962A1 Method for treating anxiety
05/22/1997WO1997017961A1 Hemoregulatory compounds
05/22/1997WO1997017956A1 Method for treating anxiety
05/22/1997WO1997017955A1 Method for treating anxiety
05/22/1997CA2237311A1 Method for treating anxiety
05/22/1997CA2237220A1 Method for treating anxiety
05/22/1997CA2236832A1 Substituted piperidine derivatives as selective agonists of 5-ht receptors
05/22/1997CA2236594A1 Method for treating anxiety
05/22/1997CA2235855A1 Morpholine derivatives and their use as therapeutic agents
05/21/1997EP0774256A1 Use of azacyclic or azabicyclic thiadiazole compounds for treating anxiety
05/21/1997EP0773946A1 Imidazopyridine-azolidinones
05/21/1997EP0773945A1 Acyl imidazopyridines
05/21/1997EP0773944A1 Benzyl-imidazopyridines
05/21/1997EP0773943A1 Compounds useful as antiproliferative agents and garft inhibitors
05/21/1997EP0773942A1 4-indole derivatives as serotonin agonists and antagonists
05/21/1997EP0773940A1 Process for synthesis of substituted sulphoxides
05/21/1997EP0773927A2 Benzoylguanidine derivatives as medicaments
05/21/1997EP0724585B1 Hydantoin derivatives and their use as bleach activators
05/21/1997CN1150428A Corticotropin releasing factor antagonists
05/20/1997US5631380 Herbicidal sulphonylaminocarbonyltriazolinones having two substituents bonded via oxygen
05/20/1997US5631374 Reagents for detection of primary amines
05/20/1997US5631266 Bactericides effective against staphylococcus
05/20/1997US5631265 Chemical intermediates with central nervous system activity
05/20/1997US5631264 Substituted 6,11-ethano-6,11-dihydrobenzo[B]quinolizinium salts and compositions and methods of use thereof
05/20/1997US5631259 Cycloalkltriols containing cyclic substituents, processes and intermediate products for their preparation and their use as antiviral and antiparasitic agents
05/20/1997US5631258 Method of effecting immunosuppression by administering carbocyclic adenosine analogs
05/20/1997US5631256 Antimicrobial quinolone thioureas
05/20/1997CA2073340C Centrally acting 6,7,8,9-tetrahydro-3h-benz(e)indole heterocyclics
05/20/1997CA2044515C Cyclic amide derivatives
05/20/1997CA2019841C 4,5-dihydro-6h-imidazo[4,5,1-ij]quinolin-6-one-6- oxime-o-sulfonic acid derivatives
05/15/1997WO1997017344A1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
05/15/1997WO1997017070A1 Inhibitors of protein isoprenyl transferases
05/15/1997DE19542189A1 New cyclic alpha-imino:hydroxamic acid derivatives
05/15/1997CA2235301A1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
05/14/1997EP0773219A1 Imidazoquinoline derivative
05/14/1997EP0773027A1 Use of azacyclic or azabicyclic pyrazine compounds for treating anxiety
05/14/1997EP0773026A2 NK-1 receptor antagonists for the treatment of cancer
05/14/1997EP0773021A1 Use of azacyclic or azabicyclic oxadiazole compounds for treating anxiety
05/14/1997EP0772614A1 Halogenated imidazopyridines
05/14/1997EP0772612A1 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one derivatives as nmda antagonists
05/14/1997EP0772611A1 Piperazine thiopyridines for controlling helicobacter bacteria
05/14/1997EP0772596A1 INDOLIZINE sPLA2 INHIBITORS
05/14/1997CN1149869A Substituted sulfonamides as selective beta3 agonists for treatment of diabetes and obesity
05/14/1997CN1149584A Preparing matrine and matrine oxide from sophora alopecuroide and its producing technology
05/13/1997US5629326 Analgesics and antipsychotics, indazole, benzisoxazole, and benzisothiazole derivatives
05/13/1997US5629322 Treatment of neurodegenerative disorders, disorders of gastrointestinal motility and inflammation
05/13/1997US5629319 Quindoline alkaloids
05/13/1997US5629317 Serotonin antagonist
05/13/1997US5628999 Hypoglycemic agent from cryptolepis
05/09/1997WO1997016451A1 Fused tropane-derivatives as neurotransmitter reuptake inhibitors
05/09/1997WO1997016440A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
05/09/1997CA2234701A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
05/07/1997EP0771319A1 Tricyclic compounds, their production and use
05/07/1997EP0771197A1 Use of heterocyclic compounds as dopamines-d 3? ligands
05/07/1997CN1149295A Tricyclic Dicarbonyl derivatives
05/07/1997CN1149252A Novel substituted tryptamines, phenalkylamines and related compounds
05/07/1997CA2189501A1 Nk-1 receptor antagonists for the treatment of cancer
05/06/1997US5627281 Chemcal intermediates for viricides by inducing synthesis of interferons
05/06/1997US5627196 Antidepressants and antiserotonin agents
05/06/1997US5627191 Therapeutic agents
05/06/1997US5627181 6-membered nitrogen-containing heteroaryl-oxazolidinones
05/06/1997US5627138 Substituted phthalides and heterocyclic phthalides
05/06/1997US5627137 Substituted phthalides and heterocyclic phthalides
05/02/1997EP0770614A2 Pyrrolo(4,3,2-de)quinoline derivative
05/02/1997EP0770081A1 Heterocycle-condensed morphinoid derivatives
05/02/1997EP0770080A1 Novel deazapurine derivatives; a new class of crf1 specific ligands
05/02/1997EP0770079A1 Heterobicyclic derivatives
05/02/1997EP0770078A1 8-aryl-1,6-naphthyridin-5-ones
05/02/1997EP0770064A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
05/02/1997EP0769966A1 Biotin compounds for targetting tumors and sites of infection
05/01/1997WO1997015576A1 Herbicidal sulfonamides
05/01/1997WO1997015574A1 Polymorphic forms of a growth hormone secretagogue
05/01/1997WO1997015573A1 Process for the preparation of a growth hormone secretagogue
05/01/1997WO1997015191A1 Wet granulation formulation of a growth hormone secretagogue
05/01/1997CA2235511A1 Process for the preparation of a growth hormone secretagogue
05/01/1997CA2235371A1 Polymorphic forms of a growth hormone secretagogue
05/01/1997CA2234817A1 Wet granulation formulation of a growth hormone secretagogue
04/1997
04/30/1997CN1148855A Novel spiro [indole-pyrrolidine]derivatives as melatoninergic agonists, method for preparing same and use thereof as drug
04/30/1997CN1148848A N-aryl and N-alkylsulphonylaminals as pesticides
04/30/1997CN1148811A Compound having antihypertensive, cardioprotective, anti-ischemic and antilipolytic functions
04/30/1997CN1148596A Noval crystal type anhydrous 7-([1 alpha, 5 alpha, 6 alpha]-6-amino-3-azabicyclo[3,1,0]hexyl-3-group)-6-fluorine-1-(2,4-difluorophenyl
04/30/1997CN1148585A Soluble chromophore containing solubilizing group easy to be removed
04/30/1997CN1034733C Spiro piperidines and homologs which promote release of growth hormone
04/29/1997US5625081 Fluorescent dye intermediates
04/29/1997US5625074 Sulphonylaminocarbonyltriazolinones
04/29/1997US5625063 Certain aryl fused imidazaopyrimidines; a new class of GABA brain receptor ligands
04/29/1997US5625061 Graft=glycinamide riboncleotide formyl transferase
04/29/1997US5624935 Antidiabetic agents, hypoglycemic agents or antilipemic agents
04/29/1997US5624933 Multistage process with halogenation, cyclization and hydrogenation
04/29/1997US5624930 Carbocyclic nucleoside analogs useful as immunosuppressants
04/29/1997US5624929 Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds
04/29/1997US5624927 N-[4-(heteroaryl)-1-piperazinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines and n-[4(heteroaryl)-1-piperazinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines, related compounds and their therapeutic utility
04/29/1997US5624924 Quinobenzothiazine antineoplastic agents
04/29/1997US5624922 Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents
04/24/1997WO1997014691A1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
04/24/1997WO1997014686A1 Pharmaceutically active quinazoline compounds